These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 9645485)

  • 1. Dipeptidyl peptidase IV (DP IV, CD26) is involved in regulation of DNA synthesis in human keratinocytes.
    Reinhold D; Vetter RW; Mnich K; Bühling F; Lendeckel U; Born I; Faust J; Neubert K; Gollnick H; Ansorge S
    FEBS Lett; 1998 May; 428(1-2):100-4. PubMed ID: 9645485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA synthesis in cultured human keratinocytes and HaCaT keratinocytes is reduced by specific inhibition of dipeptidyl peptidase IV (CD26) enzymatic activity.
    Vetter R; Reinhold D; Bühling F; Lendeckel U; Born I; Faust J; Neubert K; Ansorge S; Gollnick H
    Adv Exp Med Biol; 2000; 477():167-71. PubMed ID: 10849744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitors of dipeptidyl peptidase IV/CD26 suppress activation of human MBP-specific CD4+ T cell clones.
    Reinhold D; Hemmer B; Gran B; Born I; Faust J; Neubert K; McFarland HF; Martin R; Ansorge S
    J Neuroimmunol; 1998 Jul; 87(1-2):203-9. PubMed ID: 9670864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitors of dipeptidyl peptidase IV (DP IV, CD26) induces secretion of transforming growth factor-beta 1 (TGF-beta 1) in stimulated mouse splenocytes and thymocytes.
    Reinhold D; Bank U; Bühling F; Täger M; Born I; Faust J; Neubert K; Ansorge S
    Immunol Lett; 1997 Jun; 58(1):29-35. PubMed ID: 9436466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitors of dipeptidyl peptidase IV (DP IV, CD26) specifically suppress proliferation and modulate cytokine production of strongly CD26 expressing U937 cells.
    Reinhold D; Bank U; Bühling F; Kähne T; Kunt D; Faust J; Neubert K; Ansorge S
    Immunobiology; 1994 Dec; 192(1-2):121-36. PubMed ID: 7750986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of dipeptidyl peptidase IV (DP IV)-like enzymes in T lymphocyte activation: investigations in DP IV/CD26-knockout mice.
    Reinhold D; Goihl A; Wrenger S; Reinhold A; Kühlmann UC; Faust J; Neubert K; Thielitz A; Brocke S; Täger M; Ansorge S; Bank U
    Clin Chem Lab Med; 2009; 47(3):268-74. PubMed ID: 19676138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dipeptidyl peptidase IV (CD26): role in T cell activation and autoimmune disease.
    Reinhold D; Hemmer B; Gran B; Steinbrecher A; Brocke S; Kähne T; Wrenger S; Born I; Faust J; Neubert K; Martin R; Ansorge S
    Adv Exp Med Biol; 2000; 477():155-60. PubMed ID: 10849742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitors of dipeptidyl peptidase IV induce secretion of transforming growth factor-beta 1 in PWM-stimulated PBMC and T cells.
    Reinhold D; Bank U; Bühling F; Lendeckel U; Faust J; Neubert K; Ansorge S
    Immunology; 1997 Jul; 91(3):354-60. PubMed ID: 9301523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting dipeptidyl peptidase IV (CD26) suppresses autoimmune encephalomyelitis and up-regulates TGF-beta 1 secretion in vivo.
    Steinbrecher A; Reinhold D; Quigley L; Gado A; Tresser N; Izikson L; Born I; Faust J; Neubert K; Martin R; Ansorge S; Brocke S
    J Immunol; 2001 Feb; 166(3):2041-8. PubMed ID: 11160254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enzymatic activity of DPIV/CD26 is involved in PMA-induced hyperphosphorylation of p56lck.
    Kähne T; Neubert K; Ansorge S
    Immunol Lett; 1995 May; 46(1-2):189-93. PubMed ID: 7590918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attractin, a dipeptidyl peptidase IV/CD26-like enzyme, is expressed on human peripheral blood monocytes and potentially influences monocyte function.
    Wrenger S; Faust J; Friedrich D; Hoffmann T; Hartig R; Lendeckel U; Kähne T; Thielitz A; Neubert K; Reinhold D
    J Leukoc Biol; 2006 Sep; 80(3):621-9. PubMed ID: 16835316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitors of dipeptidyl peptidase IV-like activity mediate antifibrotic effects in normal and keloid-derived skin fibroblasts.
    Thielitz A; Vetter RW; Schultze B; Wrenger S; Simeoni L; Ansorge S; Neubert K; Faust J; Lindenlaub P; Gollnick HP; Reinhold D
    J Invest Dermatol; 2008 Apr; 128(4):855-66. PubMed ID: 17943180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dipeptidyl peptidase IV (DP IV, CD26) and aminopeptidase N (APN, CD13) as regulators of T cell function and targets of immunotherapy in CNS inflammation.
    Reinhold D; Biton A; Pieper S; Lendeckel U; Faust J; Neubert K; Bank U; Täger M; Ansorge S; Brocke S
    Int Immunopharmacol; 2006 Dec; 6(13-14):1935-42. PubMed ID: 17161346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Divergent actions by inhibitors of DP IV and APN family enzymes on CD4+ Teff cell motility and functions.
    Biton A; Ansorge S; Bank U; Täger M; Reinhold D; Brocke S
    Immunobiology; 2011 Dec; 216(12):1295-301. PubMed ID: 21802166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dipeptidyl peptidase IV (DP IV/CD26) mRNA expression in PWM-stimulated T-cells is suppressed by specific DP IV inhibition, an effect mediated by TGF-beta(1).
    Arndt M; Lendeckel U; Spiess A; Faust J; Neubert K; Reinhold D; Ansorge S
    Biochem Biophys Res Commun; 2000 Aug; 274(2):410-4. PubMed ID: 10913352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of arthritis by the inhibitors of dipeptidyl peptidase IV.
    Tanaka S; Murakami T; Horikawa H; Sugiura M; Kawashima K; Sugita T
    Int J Immunopharmacol; 1997 Jan; 19(1):15-24. PubMed ID: 9226475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific inhibitors of dipeptidyl peptidase IV suppress mRNA expression of DP IV/CD26 and cytokines.
    Arndt M; Reinhold D; Lendeckel U; Spiess A; Faust J; Neubert K; Ansorge S
    Adv Exp Med Biol; 2000; 477():139-43. PubMed ID: 10849740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and functional role of dipeptidyl peptidase IV (CD26) on human natural killer cells.
    Bühling F; Kunz D; Reinhold D; Ulmer AJ; Ernst M; Flad HD; Ansorge S
    Nat Immun; 1994; 13(5):270-9. PubMed ID: 7833626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early phosphorylation events induced by DPIV/CD26-specific inhibitors.
    Kähne T; Neubert K; Faust J; Ansorge S
    Cell Immunol; 1998 Oct; 189(1):60-6. PubMed ID: 9758695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of human immunodeficiency virus type 1 infection in a T-cell line (CEM) by new dipeptidyl-peptidase IV (CD26) inhibitors.
    Jiang JD; Wilk S; Li J; Zhang H; Bekesi JG
    Res Virol; 1997; 148(4):255-66. PubMed ID: 9272576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.